EFTA01203591.pdf

From: Vahe Stepanian To: Jeffrey Epstein <[email protected]> Daniel Sabba ,Ariane D er , Paul Moms , Stewart Oldfield , Richard Kahn Subject: FMI Update [SC J Date: Thu, 30 Jul 2015 18:26:22 +0000 Inline-Images: image001.jpg Classification: Strictly Confidential Jeffrey — as you may have seen, FMI reported earnings after the close yesterday. The stock is down - 24% today on the back of the report — additional details below. Recall that you're currently long 49,830 FMI @ average of $25.3870/sh. Thank you, Vahe FMI US $ 122.14 -7.16 — K22.10 /22.11P 1 x3 .11il At 14:13 Vol 1,175,088 0 24.000 H 24.88D 21.85K Val 26.81M IIMERIMMI I 9Q Export to Excel Page 1/6 Historical Prkx?TatakTP Foundation Medicine Inc 50.93 on 04/08/15 Range Market wag/2014n ovapj_zm n Last Price lel Volume Period Cut-re-xi; a Low Average 18.67 33.3701 on 10/01/14 313,901 View Price Table Net Chg -1.20 -5.14% I Date Last Price VolunieT Date Last Price Volume) - Datil Last Price' Volume Fr 07/31/15 cp , 07/1:, 33.17 8S,462 Fr 06/19/15 31.64 561,165 Th 07/30/15 22.14 1,175,088 07/09/15 32.35 91,870 Th 06/18/15 32.23 161,729 We 07/29/15 29.30 237,380 07/08/15 32.44 148,233 We 06/17/15 31.88 158,818 Tu 07/28/15 30.02 268,450 07/07/15 34.13 153,167 Tu 06/16/15 31.67 273,460 Mo 07/27/15 30.47 225,253 07/06/15 33.10 136,883 Mo 06/15/15 32.10 405,891 Fr 07/24/15 31.68 156,671 07/03/15 Fr 06/12/15 32.90 407,104 Th 07/23/15 32.78 158,749 07/02/15 32.88 98,909 Th 06/11/15 35.35 267,877 We 07/22/15 32.48 180,076 07/01/15 33.88 129,754 We 06/10/15 35.29 108,881 Tu 07/21/15 32.71 123,166 06/30/15 33.84 140,644 Tu 06/09/15 35.265 121,736 Mo 07/20/15 32.91 273,277 06/29/15 32.56 137,467 Mo 06/08/15 35.38 116,793 Fr 07/17/15 32.58 154,178 06/26/15 33.99 569,944 Fr 06/05/15 35.61 186,524 Th 07/16/15 33.02 110,693 06/25/15 34.08 418,002 Th 06/04/15 35.41 157,497 We 07/15/15 32.74 80.202 06/24/15 32.82 191,273 We 06/03/15 35.78 197,339 Tu 07/14/15 33.37 147,943 06/23/15 33.40 202,011 Tu 06/02/15 35.46 228,099 07/13/15 33.45 93,268 06/22/15 33.59 231,350 Mo 06/01/15 35.00 205,576 Original Message From: Vahe Stepanian (DEUTSCHE BANK SECURI) (mailto:[email protected]] Sent: Thursday, July 30, 2015 2:18 PM Subject: (BFW) Foundation Medicine Shrs Drops; 2Q Loss Per Shr Wider Than EFTA01203591 (BFW) Foundation Medicine Shrs Drops; 2Q Loss Per Shr Wider Than Ests. This has been prepared solely for informational purposes. It is not an offer, recommendation or solicitation to buy or sell, nor is it an official confirmation of terms. It is based on information generally available to the public from sources believed to be reliable. No representation is made that it is accurate or complete or that any returns indicated will be achieved. Changes to assumptions may have a material impact on any returns detailed. Past performance is not indicative of future returns. Price and availability are subject to change without notice. Additional information is available upon request. Foundation Medicine Shrs Drops; 2Q Loss Per Shr Wider Than Ests. 2015-07-29 20:16:45.919 GMT By Sasha Damouni (Bloomberg) -- Foundation Medicine 2Q loss per share 98c vs est. loss 53c. * Down 11% post-mkt on 24k vol. * Sees 2015 rev. $85m-$95m, had seen $105m-115m; est. $105.9m * 2Q rev. $22.5m vs est. $24.4m * Call at 4:30pm on 855-420-0652, pw 77633971 Link to Statement:Link For Related News and Information: First Word scrolling panel: FIRST<GO> First Word newswire: NH BFW<GO> To contact the reporter on this story: Sasha Damouni in New York at +1-212-617-7787 or sdamouni2Pbloomberg.net To contact the editors responsible for this story: Arie Shapira at +1-212-617-1488 or [email protected] Stefanie Batcho-Lino This communication may contain confidential and/or privileged information. If you are not the intended recipient (or have received this communication in error) please notify the sender immediately and destroy this communication. Any unauthorized copying, disclosure or distribution of the material in this communication is strictly forbidden. Deutsche Bank does not render legal or tax advice, and the information contained in this communication should not be regarded as such. EFTA01203592